Vaccines (Feb 2021)

Influenza and Pneumococcal Vaccination in Non-Infected Cardiometabolic Patients from the Americas during the COVID-19 Pandemic. A Sub-Analysis of the CorCOVID-LATAM Study

  • Álvaro Sosa Liprandi,
  • Ezequiel José Zaidel,
  • Ricardo Lopez Santi,
  • John Jairo Araujo,
  • Manuel Alfonso Baños González,
  • Juan Martín Busso,
  • Luz Cabral,
  • Jorge Camilletti,
  • Juan Erriest,
  • Roberto Flores,
  • Ezequiel Forte,
  • Mirecly Guzman Ramos,
  • Máxima Mendez Castillo,
  • Leonardo Josué Ramírez Zambrano,
  • Carmen Roa,
  • Piero Custodio–Sanchez,
  • Gustavo Solache Ortiz,
  • Bernardo Spitz,
  • Adrián Baranchuk

DOI
https://doi.org/10.3390/vaccines9020123
Journal volume & issue
Vol. 9, no. 2
p. 123

Abstract

Read online

Background: Influenza vaccination (IV) and Pneumococcus vaccination (PV) are recommended for patients with cardiometabolic diseases. This study aimed to evaluate the immunization rate of ambulatory cardiometabolic patients during the COVID-19 pandemic in the Americas. Methods: Electronic surveys were collected from 13 Spanish speaking countries between 15 June and 15 July 2020. Results: 4216 patients were analyzed. Mean age 60 (±15) years and 49% females. Global IV rate was 46.5% and PV 24.6%. Vaccinated patients were older (IV = 63 vs. 58 years; PV = 68 vs. 59, p p p p < 0.001) were predictors for vaccination. Conclusions: During the COVID-19 pandemic, ambulatory patients with cardiometabolic diseases from the Americas with no evidence of COVID-19 infection had lower-than-expected rates of IV and PV. Geographic, social, and cultural differences were found, and they should be explored in depth.

Keywords